Literature DB >> 8174422

Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori.

G Holtmann1, H Goebell, M Holtmann, N J Talley.   

Abstract

Whether Helicobacter pylori is causally linked to dyspepsia remains controversial. The aims of this study were to assess in healthy blood donors the prevalence of dyspepsia and dyspepsia subgroups, determine if H. pylori is associated with different categories of dyspeptic symptoms, and evaluate the association between dyspepsia and nicotine, alcohol, and analgesic use. Consecutive blood donors (N = 180) who had no clinical evidence of organic disease were included. Abdominal symptoms were measured by means of a standardized questionnaire that has been previously validated. Subjects with dyspepsia (defined as pain localized to the upper abdomen) were further subdivided into those with ulcer-like, dysmotility-like, reflux-like, or nonspecific dyspepsia. A total of 65 subjects reported abdominal pain or discomfort during the prior 12 months [36.1%, 95% confidence interval (CI) 29.1-43.1]; 44 subjects (24.4%, 95% CI 18.2-30.7) had dyspepsia. Dysmotility-like, reflux-like, and ulcer-like symptoms were reported by 19.4% (95% CI 13.7-25.2), 17.2% (95% CI 11.7-22.7), and 16.7% (95% CI 11.2-22.1) of subjects with dyspepsia, respectively. Fifty-seven subjects (31.7%, 95% CI 24.9-38.5) were H. pylori positive; 26% of subjects with H. pylori and 24% without H. pylori had dyspepsia (P > 0.50). The seroprevalence of H. pylori was also similar among the different categories of dyspepsia. We conclude that infection with H. pylori is not associated with abdominal complaints in otherwise healthy subjects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8174422     DOI: 10.1007/bf02087563

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  48 in total

1.  Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.

Authors:  C A McNulty; J C Gearty; B Crump; M Davis; I A Donovan; V Melikian; D M Lister; R Wise
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-13

2.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

3.  Prevalence of symptoms of dyspepsia.

Authors:  R Metcalf; G R Youngs
Journal:  BMJ       Date:  1989-02-25

4.  Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

Authors:  B J Marshall; J R Warren
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

5.  [Gastrointestinal symptoms among 40-year olds in Glostrup. An epidemiological study].

Authors:  H Hollnagel; N Nørrelund; S Larsen
Journal:  Ugeskr Laeger       Date:  1982-01-25

6.  Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays.

Authors:  N J Talley; D G Newell; J E Ormand; H A Carpenter; W R Wilson; A R Zinsmeister; G I Perez-Perez; M J Blaser
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

7.  The prevalence of symptoms of dyspepsia in north eastern Nigeria. A random community based survey.

Authors:  C Holcombe; B A Omotara; M K Padonu; A P Bassi
Journal:  Trop Geogr Med       Date:  1991 Jan-Apr

8.  Helicobacter pylori infection and non-ulcer dyspepsia: the effect of treatment with colloidal bismuth subcitrate.

Authors:  K L Goh; N Parasakthi; S C Peh; N W Wong; Y L Lo; S D Puthucheary
Journal:  Scand J Gastroenterol       Date:  1991-11       Impact factor: 2.423

9.  Comparison of the clinical features and illness behaviour of patients presenting with dyspepsia of unknown cause (essential dyspepsia) and organic disease.

Authors:  N J Talley; D W Piper
Journal:  Aust N Z J Med       Date:  1986-06

Review 10.  Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease.

Authors:  M J Blaser
Journal:  Gastroenterology       Date:  1987-08       Impact factor: 22.682

View more
  26 in total

Review 1.  Helicobacter pylori eradication in patients with non-ulcer dyspepsia.

Authors:  H H Xia; N J Talley
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

Review 2.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

3.  Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly.

Authors:  C Tait; R Jones
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

4.  Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes.

Authors:  S Rosenstock; L Kay; C Rosenstock; L P Andersen; O Bonnevie; T Jørgensen
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

5.  Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study.

Authors:  M B Wallace; V L Durkalski; J Vaughan; Y Y Palesch; E D Libby; P S Jowell; N J Nickl; S M Schutz; J W Leung; P B Cotton
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

6.  H. pylori and functional dyspepsia: increased serum antibodies as an independent risk factor?

Authors:  G Holtmann; J Gschossmann; M Holtmann; N J Talley
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

Review 7.  Gastroduodenal "Dysbiosis": a New Clinical Entity.

Authors:  Ayesha Shah; Mark Morrison; Gerald J Holtmann
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

8.  Uninvestigated dyspepsia in Latin America: a population-based study.

Authors:  Jorge A Olmos; Valeria Pogorelsky; Federico Tobal; Mariano Marcolongo; Graciela Salis; Roberto Higa; Juan Carlos Chiocca
Journal:  Dig Dis Sci       Date:  2006-10-06       Impact factor: 3.199

9.  Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.

Authors:  J Labenz; A L Blum; W W Bolten; B Dragosics; W Rösch; M Stolte; H R Koelz
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

10.  Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization.

Authors:  N Gathaiya; G R Locke; M Camilleri; C D Schleck; A R Zinsmeister; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2009-06-02       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.